Genome profiling of ERBB2-amplified breast cancers

被引：0
|
作者：
Fabrice Sircoulomb
Ismahane Bekhouche
Pascal Finetti
José Adélaïde
Azza Ben Hamida
Julien Bonansea
Stéphane Raynaud
Charlène Innocenti
Emmanuelle Charafe-Jauffret
Carole Tarpin
Farhat Ben Ayed
Patrice Viens
Jocelyne Jacquemier
François Bertucci
Daniel Birnbaum
Max Chaffanet
机构：
[1] Institut Paoli-Calmettes,Marseille Cancer Research Center, UMR891 Inserm
[2] Department of Molecular Oncology,Department of BioPathology
[3] Institut Paoli-Calmettes,Department of Medical Oncology
[4] Institut Paoli-Calmettes,Department of Medical Oncology
[5] Université de la Méditerranée,undefined
[6] Salah Azaiz Institute,undefined
来源：
BMC Cancer | / 10卷
关键词：
Epidermal Growth Factor Receptor; Estrogen Receptor; Trastuzumab; Copy Number Gain; Copy Number Aberration;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Targeting MET and ERBB2 signaling in aggressive breast cancers
    Graveel, Carrie R.
    Paulson, Amanda
    Linklater, Erik
    Berghuis, Bree
    Feenstra, Kristin
    Melnik, Marianne
    Woude, George Vande
    CANCER RESEARCH, 2012, 72
  • [42] International Harmonization of Provisional Diagnostic Criteria for ERBB2-Amplified Metastatic Colorectal Cancer Allowing for Screening by Next-Generation Sequencing Panel
    Fujii, Satoshi
    Magliocco, Anthony M.
    Kim, Jihun
    Okamoto, Wataru
    Kim, Jeong Eun
    Sawada, Kentaro
    Nakamura, Yoshiaki
    Kopetz, Scott
    Park, Woong-Yang
    Tsuchihara, Katsuya
    Kim, Tae Won
    Raghav, Kanwal
    Yoshino, Takayuki
    JCO PRECISION ONCOLOGY, 2020, 4 : 6 - 19
  • [43] Molecular distinctions among ERBB2-overexpressing breast cancers
    Jeffrey, SS
    BREAST CANCER RESEARCH, 2005, 7 (Suppl 2) : S8 - S8
  • [44] c-erbB-2 over-expression in amplified and non-amplified breast carcinoma samples
    Farabegoli, F
    Ceccarelli, C
    Santini, D
    Baldini, N
    Taffurelli, M
    Marrano, D
    Treré, D
    Derenzini, M
    INTERNATIONAL JOURNAL OF CANCER, 1999, 84 (03) : 273 - 277
  • [45] Margetuximab (M) plus pembrolizumab (P) in ERBB2-amplified PD-L1+gastroesophageal adenocarcinoma (GEA) post trastuzumab (T).
    Catenacci, Daniel V. T.
    Park, Haeseong
    Uronis, Hope Elizabeth
    Kang, Yoon-Koo
    Lacy, Jill
    Enzinger, Peter C.
    Park, Se Hoon
    Lee, Keun Wook
    Ng, Matthew C. H.
    Gold, Philip Jordan
    Yen, Jennifer
    Franovic, Aleksandra
    Kelly, Ronan Joseph
    Wynter-Horton, Aisha
    Li, Daner
    Muth, John
    Baughman, Jan E.
    Hong, Sam
    Davidson-Moncada, Jan Kenneth
    Bang, Yung-Jue
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [46] Genomic profiling of breast cancers
    Curtis, Christina
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2015, 27 (01) : 34 - 39
  • [47] Topoisomerase II alpha gene copy loss has adverse prognostic significance in ERBB2-amplified breast cancer: a retrospective study of paraffin-embedded tumor specimens and medical charts
    Usha, Lydia
    Tabesh, Bita
    Morrison, Larry E.
    Rao, Ruta D.
    Jacobson, Kris
    Zhu, April
    Basu, Sanjib
    Coon, John S.
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2008, 1 (1)
  • [48] HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers
    Li, Bob T.
    Michelini, Flavia
    Misale, Sandra
    Cocco, Emiliano
    Baldino, Laura
    Cai, Yanyan
    Shifman, Sophie
    Tu, Hai-Yan
    Myers, Mackenzie L.
    Xu, Chongrui
    Mattar, Marissa
    Khodos, Inna
    Little, Megan
    Qeriqi, Besnik
    Weitsman, Gregory
    Wilhem, Clare J.
    Lalani, Alshad S.
    Diala, Irmina
    Freedman, Rachel A.
    Lin, Nancy U.
    Solit, David B.
    Berger, Michael F.
    Barber, Paul R.
    Ng, Tony
    Offin, Michael
    Isbell, James M.
    Jones, David R.
    Yu, Helena A.
    Thyparambil, Sheeno
    Liao, Wei-Li
    Bhalkikar, Anuja
    Cecchi, Fabiola
    Hyman, David M.
    Lewis, Jason S.
    Buonocore, Darren J.
    Ho, Alan L.
    Makker, Vicky
    Reis-Filho, Jorge S.
    Razavi, Pedram
    Arcila, Maria E.
    Kris, Mark G.
    Poirier, John T.
    Shen, Ronglai
    Tsurutani, Junji
    Ulaner, Gary A.
    de Stanchina, Elisa
    Rosen, Neal
    Rudin, Charles M.
    Scaltriti, Maurizio
    CANCER DISCOVERY, 2020, 10 (05) : 674 - 687
  • [49] Topoisomerase II alpha gene copy loss has adverse prognostic significance in ERBB2-amplified breast cancer: a retrospective study of paraffin-embedded tumor specimens and medical charts
    Lydia Usha
    Bita Tabesh
    Larry E Morrison
    Ruta D Rao
    Kris Jacobson
    April Zhu
    Sanjib Basu
    John S Coon
    Journal of Hematology & Oncology, 1
  • [50] Identification of AP-2 cofactors in breast cancers overexpressing ERBB2.
    Grégory, Nolens
    ACTA CLINICA BELGICA, 2006, 61 (02): : 95 - 95
12345